Search results for "immune cell therapy"

Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

Anchoring the U.S. Supply Chain: GC Green Cross Expands 30-Year Cytiva Partnership to Secure Alyglo Production

GC Green Cross has secured priority access to critical manufacturing consumables to stabilize the production of Alyglo, its flagship blood product,...
Landmark Biotech Deal: Celltrion Acquires Autoimmune Disease Antibody Tech from Catholic University of Korea

Landmark Biotech Deal: Celltrion Acquires Autoimmune Disease Antibody Tech from Catholic University of Korea

A research team led by Kim Wan-wook at the Catholic University of Korea College of Medicine has successfully transferred a novel antibody technology...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
Navigating Stem Cell Hype: Can Any Hospital Truly Offer Regenerative Medicine?

Navigating Stem Cell Hype: Can Any Hospital Truly Offer Regenerative Medicine?

Consider a patient in their 60s whose knee cartilage has completely worn down, making every step up a flight of stairs...
United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy

United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy

The race to develop regenerative cell therapies for an ultra-rare disease that leaves patients born without a...
More Than a Sleep Aid: Melatonin Shows Promise in Easing Chronic Pain

More Than a Sleep Aid: Melatonin Shows Promise in Easing Chronic Pain

Melatonin supplements are widely celebrated for their ability to combat insomnia. As a naturally occurring sleep...
Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Treatment for inflammatory bowel disease is rapidly moving beyond simple symptom management toward the structural...
Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle mass in lung cancer patients may play a decisive role in determining the success of immunotherapy.
Radioembolization Extends Survival in Select Patients with Advanced Liver Cancer, Study Finds

Radioembolization Extends Survival in Select Patients with Advanced Liver Cancer, Study Finds

Hearing a doctor say that “the cancer has invaded the portal vein” can be deeply overwhelming for patients with liver...
When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage.